Cyclic Rgd-Linked Polymeric Micelles for Targeted Delivery of Platinum Anticancer Drugs to Glioblastoma Through the Blood-Brain Tumor Barrier

Yutaka Miura,Tomoya Takenaka,Kazuko Toh,Shourong Wu,Hiroshi Nishihara,Mitsunobu R. Kano,Yasushi Ino,Takahiro Nomoto,Yu Matsumoto,Hiroyuki Koyama,Horacio Cabral,Nobuhiro Nishiyama,Kazunori Kataoka

DOI: https://doi.org/10.1021/nn402662d

IF: 17.1

2013-01-01

ACS Nano

Abstract:Ligand-mediated drug delivery systems have enormous potential for improving the efficacy of cancer treatment. In particular, Arg-Gly-Asp peptides are promising ligand molecules for targeting αvβ3/αvβ5 integrins, which are overexpressed in angiogenic sites and tumors, such as intractable human glioblastoma (U87MG). We here achieved highly efficient drug delivery to U87MG tumors by using a platinum anticancer drug-incorporating polymeric micelle (PM) with cyclic Arg-Gly-Asp (cRGD) ligand molecules. Intravital confocal laser scanning microscopy revealed that the cRGD-linked polymeric micelles (cRGD/m) accumulated rapidly and had high permeability from vessels into the tumor parenchyma compared with the PM having nontargeted ligand, "cyclic-Arg-Ala-Asp" (cRAD). As both cRGD/m- and cRAD-linked polymeric micelles have similar characteristics, including their size, surface charge, and the amount of incorporated drugs, it is likely that the selective and accelerated accumulation of cRGD/m into tumors occurred via an active internalization pathway, possibly transcytosis, thereby producing significant antitumor effects in an orthotopic mouse model of U87MG human glioblastoma.